AstraZeneca, Bristol Myers Squibb Akan Merger? Mari Pertimbangkan Pro & Kontra (NYSE:AZN)
· seekingalpha.com
Rumor beredar mengenai mega-merger AstraZeneca–Bristol Myers Squibb: jurang paten, sinergi onkologi, dan risiko utama—dapatkan poin penting sahamnya sekarang.
If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and ...